Results 231 to 240 of about 407,965 (429)

Ultrasound guided percutaneous thrombin injection of iatrogenic femoral artery pseudoaneurysms after coronary angiography and intervention [PDF]

, 2001
John Ferguson
openalex   +1 more source

A Rare Case of Nitroglycerin Resistant Coronary Arterial Vasospasm During Coronary Artery Bypass Surgery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary artery vasospasm following coronary artery bypass grafting (CABG) is a rare but potentially life‐threatening complication that can lead to myocardial ischemia, arrhythmias, and cardiogenic shock. Nitroglycerin‐resistant vasospasm, particularly involving the left main coronary artery (LMCA), poses significant diagnostic and ...
Dina Soliman, Cristian Castillo‐Rodriguez, Diego Cruz, John Abdelmalek   +3 more
wiley   +1 more source

Prognostic value of residual SYNTAX score in patients with coronary artery disease undergoing percutaneous coronary intervention-cohort study

Indian Heart Journal
Residual Syntax Score (RSS) is derived from Syntax Score to quantify the burden of residual coronary artery disease after percutaneous coronary intervention (PCI).
Santhosh Satheesh, Ritesh Kumar, Ajith Ananthakrishna Pillai, Raja Selvaraj   +3 more
doaj  

β-Blockers Before Percutaneous Coronary Intervention Do Not Attenuate Postprocedural Creatine Kinase Isoenzyme Rise [PDF]

, 2001
Stephen G. Ellis, Sorin J. Brener, A. Michael Lincoff, David J. Moliterno, Patrick L. Whitlow, Jakob P. Schneider, Eric J. Topol   +6 more
openalex   +1 more source

Use of ReCross to Increase Success Rate With Antegrade CTO PCI—A Multicenter Observational Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Antegrade approach remains one of the predominant techniques for CTO PCI. Success rates have increased significantly recently due to advancements in devices and strategies, along with the hybrid algorithm. ReCross is a uniquely modified microcatheter with two over‐the‐wire lumens and three exit ports, offering significant potential ...
Mohamed Ayoub, Abdul Mozid, Legate Philip, Xavier Millan, Jaikirshan Khatri, Claudiu Ungureanu, Johan Bennett, Chadi Ghafari, Alexandre Avran   +8 more
wiley   +1 more source

Facilitated percutaneous coronary intervention: results from the SPEED trial [PDF]

, 2001
Howard C. Herrmann
openalex   +1 more source

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

The Lancet, 2018
R. Al-Lamee, D. Thompson, Hakim-Moulay Dehbi, S. Sen, K. Tang, J. Davies, Thomas R. Keeble, Michael Mielewczik, R. Kaprielian, I. Malik, S. Nijjer, R. Petraco, Christopher M. Cook, Y. Ahmad, J. Howard, C. Baker, A. Sharp, R. Gerber, S. Talwar, R. Assomull, J. Mayet, R. Wensel, D. Collier, M. Shun-shin, S. Thom, J. Davies, D. Francis, A. Sethi, P. Ramrakha, R. Foale, R. Khamis, N. Hadjiloizou, Masood Khan, J. Kooner, Michael F Bellamy, G. Mikhail, P. Clifford, P. O'Kane, T. Levy, R. Swallow   +39 more
semanticscholar   +1 more source

Efficacy and Safety of Intravascular Lithotripsy in the Management of Underexpanded Stents: A Systematic Review and Meta‐Analysis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Stent underexpansion significantly heightens the risk of major adverse cardiac events (MACE), and available treatment options for this condition remain limited. Intravascular Lithotripsy (IVL) technology disrupts superficial and deep calcium by using localized pulsative sonic pressure waves, emerges as a promising tool for ...
Marios Sagris, Stergios Soulaidopoulos, Angelos Papanikolaou, Nikolaos Ktenopoulos, Martijn J. H. van Oort, Jose M. Montero‐Cabezas, Nikolaos Patsourakos, Benjamin Honton, Dimitris Tousoulis, Konstantinos Tsioufis   +9 more
wiley   +1 more source

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans

Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1313-1324, May 2025.
Clopidogrel, an anti‐platelet drug, is used to prevent thrombosis after percutaneous coronary intervention. Clopidogrel resistance results in recurring ischemic events, with African Americans (AA) suffering disproportionately. The aim of this study was to discover novel biomarkers of clopidogrel resistance in African Americans using genome and ...
Guang Yang, Cristina Alarcon, Catherine Chanfreau, Norman H. Lee, Paula Friedman, Edith Nutescu, Matthew Tuck, Travis O'Brien, Li Gong, Teri E. Klein, Kyong‐Mi Chang, Philip S. Tsao, David O. Meltzer, Julie A. Lynch, Million Veteran Program, Sony Tuteja, Minoli A. Perera   +16 more
wiley   +1 more source

Defining the Optimal Activated Clotting Times During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials [PDF]

, 2001
Gérard Helft, Farzin Beygui, Claude Le Feuvre, J Metzger   +3 more
openalex   +1 more source